- Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms. OncoImmunology. 2018 Academic Article GET IT
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts.
Times cited: 23
Cytokine-induced killer cells engineered with exogenous t-cell receptors directed against melanoma antigens: Enhanced efficacy of effector cells endowed with a double mechanism of tumor recognition.
Human Gene Therapy.
Times cited: 7